|
|
37661
|
Y41.9
|
ADVERSE EFFECTS IN THERAPEUTIC USE, SYSTEMIC ANTI-INFECTIVES AND ANTIPARASITICS, More ...
|
|
|
37662
|
Y42
|
ADVERSE EFFECTS, HORMONES AND THEIR SYNTHETIC SUBSTITUTES AND ANTAGONISTS, NOT E More ...
|
|
|
37663
|
Y42.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, GLUCOCORTICOIDS AND SYNTHETIC ANALOGUES
|
|
|
37664
|
Y42.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, THYROID HORMONES AND SUBSTITUTES
|
|
|
37665
|
Y42.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTITHYROID DRUGS
|
|
|
37666
|
Y42.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, INSULIN AND ORAL HYPOGLYCAEMIC [ANTIDIABETIC More ...
|
|
|
37667
|
Y42.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ORAL CONTRACEPTIVES
|
|
|
37668
|
Y42.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER ESTROGENS AND PROGESTOGENS
|
|
|
37669
|
Y42.6
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTIGONADOTROPHINS, ANTIESTROGENS, ANTIANDRO More ...
|
|
|
37670
|
Y42.7
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANDROGENS AND ANABOLIC CONGENERS
|
|
|
37671
|
Y42.8
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED HORMONES AND THEIR SYN More ...
|
|
|
37672
|
Y42.9
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER AND UNSPECIFIED HORMONE ANTAGONISTS
|
|
|
37673
|
Y43
|
ADVERSE EFFECTS IN THERAPEUTIC USE, PRIMARILY SYSTEMIC AGENTS
|
|
|
37674
|
Y43.0
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTIALLERGIC AND ANTIEMETIC DRUGS
|
|
|
37675
|
Y43.1
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTINEOPLASTIC ANTIMETABOLITES
|
|
|
37676
|
Y43.2
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ANTINEOPLASTIC NATURAL PRODUCTS
|
|
|
37677
|
Y43.3
|
ADVERSE EFFECTS IN THERAPEUTIC USE, OTHER ANTINEOPLASTIC DRUGS
|
|
|
37678
|
Y43.4
|
ADVERSE EFFECTS IN THERAPEUTIC USE, IMMUNOSUPPRESSIVE AGENTS
|
|
|
37679
|
Y43.5
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ACIDIFYING AND ALKALIZING AGENTS
|
|
|
37680
|
Y43.6
|
ADVERSE EFFECTS IN THERAPEUTIC USE, ENZYMES, NOT ELSEWHERE CLASSIFIED
|